1383383-33-2

Basic information

• Product Name: 5-(3-acetylamino-phenyl)-3-[1-ethyl-5-(4-methyl-cyclohexyl)-1,2,3,6-tetrahydro-pyridin-4-yl]-thiophene-2-carboxylic acid
• Synonyms: 5-(3-acetylamino-phenyl)-3-[1-ethyl-5-(4-methyl-cyclohexyl)-1,2,3,6-tetrahydro-pyridin-4-yl]-thiophene-2-carboxylic acid
• CAS NO: 1383383-33-2
• Molecular Weight: 466.645
• Mol File: 1383383-33-2.mol

Chemical Properties

• CAS DataBase Reference: 5-(3-acetylamino-phenyl)-3-[1-ethyl-5-(4-methyl-cyclohexyl)-1,2,3,6-tetrahydro-pyridin-4-yl]-thiophene-2-carboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 5-(3-acetylamino-phenyl)-3-[1-ethyl-5-(4-methyl-cyclohexyl)-1,2,3,6-tetrahydro-pyridin-4-yl]-thiophene-2-carboxylic acid(1383383-33-2)
• EPA Substance Registry System: 5-(3-acetylamino-phenyl)-3-[1-ethyl-5-(4-methyl-cyclohexyl)-1,2,3,6-tetrahydro-pyridin-4-yl]-thiophene-2-carboxylic acid(1383383-33-2)

Safety Data

• Hazardous Substances Data: 1383383-33-2(Hazardous Substances Data)

Upstream product

• 1383385-13-4 C₂₈H₃₆N₂O₃S 
• 1383385-12-3 C₂₆H₃₄N₂O₂S 
• 1383385-11-2 C₃₁H₄₂N₂O₄S 
• 1383385-02-1 C₂₀H₂₉NO₂S 
• 1383385-01-0 C₂₀H₂₆NO₂S⁽¹⁺⁾*I^(1-) 
• 1383385-03-2 C₂₀H₂₈INO₂S 
• 1383384-93-7 C₁₈H₂₁NO₂S 
• 1383384-92-6 C₁₈H₁₉NO₂S 
• 1383384-91-5 C₁₁H₈BrNO₂S 
• 62353-77-9 3-iodothiophene-2-carboxylic acid methyl ester 
• 865869-26-7 4,4,5,5-tetramethyl-2-(4-methylcyclohex-1-en-1-yl)-1,3,2-dioxaborolane 
• 119472-66-1 4-methylcyclohex-1-en-1-yl trifluoromethanesulfonate 
• 22288-78-4 Methyl 3-aminothiophene-2-carboxylate 
• 108-94-1 cyclohexanone 

Relevant articles and documents

INHIBITORS OF HEPATITIS C VIRUS POLYMERASE

The present invention provides, among other things, compounds represented by the general Formula (I) and pharmaceutically acceptable salts thereof, wherein X, Y, R1A, R1B, R2, and R3 are as defined in classes and subclasses herein and compositions (e.g., pharmaceutical compositions) comprising such compounds, which compounds are useful as inhibitors of hepatitis C virus polymerase, and thus are useful, for example, as medicaments for the treatment of HCV infection.